Liver (Hepatic Glucose and Lipid Metabolism): By suppressing glucagon and increasing insulin, GLP-1 RAs reduce hepatic glucose production (gluconeogenesis) (Zheng et al., 2024)
This is important because it suggests that glucagon receptor activation, when balanced by incretin co-agonism, does not automatically negate glycemic benefit
Each DEXA scan body fat report will allow you to calculate what fraction of your weight loss is fat vs
In our first round of syntheses, the known helical portion of GLP-1 spanning residues 931 was scanned with Ala u triads (A u A u A u )
These are exposure ratios, not percent converted, and they decline over time with continued use
According to the SmPC, the medication should be titrated gradually: starting at 0.25 mg once weekly for 4 weeks (initiation dose only), then increasing to 0.5 mg